Back
EyePoint Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
EYPT
EyePoint Pharmaceuticals
Last Price:
$9.85
Seasonality Move:
-0.5%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.17 | Sell |
| 20-day SMA: | 9.62 | Buy |
| 50-day SMA: | 8.01 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 7.49 | Buy |
| 20-day EMA: | 4.13 | Buy |
| 50-day EMA: | 1.9 | Buy |
| 200-day EMA: | 0.51 | Buy |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.59 | Buy |
| Relative Strength Index (14 RSI): | 59.31 | Buy |
| Chaikin Money Flow: | -520524 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.75 - 10.23) | Buy |
| Bollinger Bands (100): | (5.41 - 8.65) | Buy |
EyePoint Pharmaceuticals Technical Analysis
| Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 10.17 while EYPT 8-day simple moving average is 10.17, which is a Sell signal.
-
The stock price of EYPT is 10.17 while EyePoint Pharmaceuticals 20-day SMA is 9.62, which makes it a Buy.
-
EyePoint Pharmaceuticals 50-day simple moving average is 8.01 while EYPT share price is 10.17, making it a Buy technically.
-
EYPT stock price is 10.17 and EyePoint Pharmaceuticals 200-day simple moving average is 7.88, creating a Buy signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
45
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $10.17. The Score for EYPT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
699.8M
Price in USD:
10.17
Share Volume:
545.3K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
13.99
52-Week Low:
3.91
Sell
45
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 10.17 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 10.17 while EYPT 8-day exponential moving average is 7.49, which is a Buy signal.
-
The stock price of EYPT is 10.17 while EyePoint Pharmaceuticals 20-day EMA is 4.13, which makes it a Buy.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 1.90 while EYPT share price is 10.17, making it a Buy technically.
-
EYPT stock price is 10.17 and EyePoint Pharmaceuticals 200-day simple moving average is 0.51, creating a Buy signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.07 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is 2.59, suggesting EyePoint Pharmaceuticals is a Buy
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 59.31, which suggest EyePoint Pharmaceuticals is overbought
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.75 - 10.23), which suggest EyePoint Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (5.41 - 8.65), which suggest EyePoint Pharmaceuticals is a Buy
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.